Actos Bests Avandia in New Study

Already under attack for potential heart risks, the diabetes drug Avandia is taking fresh hits from two new studies published Sept. 11 in the Journal of the American Medical Association.

Reports of Drug Side Effects Rise

U.S. regulators received more than twice as many reports of deadly or debilitating side effects from drug treatment in 2005 as they did seven years before, a study found.

Diseases Associated with Asbestos

The use of asbestos has declined sharply over the last several decades as people became more aware of the serious health consequences associated with asbestos exposure.

Avandia Should be Pulled, say Authors of Studies

Two studies and an editorial today should lead the Food and Drug Administration to pull the diabetes pill Avandia off the market, the authors say.

More Studies Cast Doubt on Safety of Diabetes Drug

Two more studies published in yet another prominent medical journal have raised questions about the safety of Avandia, a once-popular diabetes medicine.

Avandia Safety Questioned by More Studies

Avandia has come under fire again, after two more studies raised additional concerns over the safety of the diabetes medication.

Libby, Montana The Asbestos Nightmare

For those unfamiliar with the story, the W.R. Grace company operated a vermiculite mine and harvested tremolite, a dangerous form of asbestos, from 1963 to 1990, despite knowing as early as the 1950's that tremolite posed a serious public health risk.

Burden of Proof

Pointing to risks linked to FDA-approved drugs, a researcher argues that the agency should require more testing, a route some say could keep life-saving medication off the market for years

3 Nevadans take on Drugmaker

The women have shared the trauma of facing a cancer that threatened their lives. But they have another factor in common: years spent taking hormone replacement therapy drugs to counter the effects of menopause.

3 Nevada Women take on Drug Maker in Hormone Replacement Trial

Three northern Nevada women are scheduled to go to trial this week against Wyeth Pharmaceuticals in the latest lawsuit claiming that the company's hormone replacement drugs cause breast cancer.